BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 25449358)

  • 21. Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats.
    Okada M; Nakagawa T; Minami M; Satoh M
    J Pharmacol Exp Ther; 2002 Oct; 303(1):66-73. PubMed ID: 12235234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of effect of a P2Y6 receptor antagonist on neuropathic pain behavior in mice.
    Syhr KM; Kallenborn-Gerhardt W; Lu R; Olbrich K; Schmitz K; Männich J; Ferreiros-Bouzas N; Geisslinger G; Niederberger E; Schmidtko A
    Pharmacol Biochem Behav; 2014 Sep; 124():389-95. PubMed ID: 25042778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological and second messenger signalling selectivities of cloned P2Y receptors.
    Nicholas RA; Lazarowski ER; Watt WC; Li Q; Boyer J; Harden TK
    J Auton Pharmacol; 1996 Dec; 16(6):319-23. PubMed ID: 9131407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of contractile P2Y1, P2Y6, and P2Y12 receptors in rat intrapulmonary artery using selective ligands.
    Mitchell C; Syed NI; Tengah A; Gurney AM; Kennedy C
    J Pharmacol Exp Ther; 2012 Dec; 343(3):755-62. PubMed ID: 22991416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UDP/P2Y6 receptor signaling regulates IgE-dependent degranulation in human basophils.
    Nakano M; Ito K; Yuno T; Soma N; Aburakawa S; Kasai K; Nakamura T; Takami H
    Allergol Int; 2017 Oct; 66(4):574-580. PubMed ID: 28318884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alanine-(87)-threonine polymorphism impairs signaling and internalization of the human P2Y11 receptor, when co-expressed with the P2Y1 receptor.
    Haas M; Shaaban A; Reiser G
    J Neurochem; 2014 May; 129(4):602-13. PubMed ID: 24524250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hetero-oligomerization of the P2Y11 receptor with the P2Y1 receptor controls the internalization and ligand selectivity of the P2Y11 receptor.
    Ecke D; Hanck T; Tulapurkar ME; Schäfer R; Kassack M; Stricker R; Reiser G
    Biochem J; 2008 Jan; 409(1):107-16. PubMed ID: 17824841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological characterization of P2Y receptor subtypes - an update.
    von Kügelgen I
    Purinergic Signal; 2024 Apr; 20(2):99-108. PubMed ID: 37697211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of P2Y6 receptors in the maintenance of neuropathic pain and its improvement of oxidative stress in rats.
    Wang Z; Zhao W; Shen X; Wan H; Yu JM
    J Cell Biochem; 2019 Oct; 120(10):17123-17130. PubMed ID: 31106899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of peripheral and spinal 5-HT6 receptors according to the rat formalin test.
    Castañeda-Corral G; Rocha-González HI; Araiza-Saldaña CI; Ambriz-Tututi M; Vidal-Cantú GC; Granados-Soto V
    Neuroscience; 2009 Aug; 162(2):444-52. PubMed ID: 19422883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
    Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
    Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agonists and Antagonists for Purinergic Receptors.
    Müller CE; Baqi Y; Namasivayam V
    Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The activation of P2Y6 receptor in cultured spinal microglia induces the production of CCL2 through the MAP kinases-NF-κB pathway.
    Morioka N; Tokuhara M; Harano S; Nakamura Y; Hisaoka-Nakashima K; Nakata Y
    Neuropharmacology; 2013 Dec; 75():116-25. PubMed ID: 23916475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinoma-specific expression of P2Y11 receptor and its contribution in ATP-induced purinergic signalling and cell migration in human hepatocellular carcinoma cells.
    Khalid M; Brisson L; Tariq M; Hao Y; Guibon R; Fromont G; Mortadza SAS; Mousawi F; Manzoor S; Roger S; Jiang LH
    Oncotarget; 2017 Jun; 8(23):37278-37290. PubMed ID: 28418839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P2Y
    Communi D; Horckmans M; Boeynaems JM
    Biochem Pharmacol; 2021 May; 187():114347. PubMed ID: 33232731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of acid-sensing ion channel activity by metabotropic P2Y UTP receptors in primary sensory neurons.
    Ren C; Gan X; Wu J; Qiu CY; Hu WP
    Purinergic Signal; 2016 Mar; 12(1):69-78. PubMed ID: 26538146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purinergic P2Y6 receptors induce Ca2+ and CFTR dependent Cl- secretion in mouse trachea.
    Schreiber R; Kunzelmann K
    Cell Physiol Biochem; 2005; 16(1-3):99-108. PubMed ID: 16121038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purinergic receptors in human placenta: evidence for functionally active P2X4, P2X7, P2Y2, and P2Y6.
    Roberts VH; Greenwood SL; Elliott AC; Sibley CP; Waters LH
    Am J Physiol Regul Integr Comp Physiol; 2006 May; 290(5):R1374-86. PubMed ID: 16373435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of ATP receptors in the rat dorsal root ganglion and spinal cord.
    Kobayashi K; Yamanaka H; Noguchi K
    Anat Sci Int; 2013 Jan; 88(1):10-6. PubMed ID: 23179910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology and structure of P2Y receptors.
    von Kügelgen I; Hoffmann K
    Neuropharmacology; 2016 May; 104():50-61. PubMed ID: 26519900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.